Rebecca Diller, PA
Physician Assistant · Monroe, NCNPI 1316122781
Payments from drug & device makers
Across 93 payments — averaging $32.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Pharmacyclics LLC, An Abbvie Company$204
- Johnson & Johnson$198
- Sanofi$196
- Gilead$137
- Incyte Corporation$133
- plus $547 from 17 others
What the payments were for
- Food & beverage$1,25841%
- Education$2769%
- Other$1,53150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 26 | $1,651 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $204 |
| Johnson & Johnson | 9 | $198 |
| Sanofi | 11 | $196 |
| Gilead(2 entities) | 8 | $137 |
| Incyte Corporation | 3 | $133 |
| Merck | 6 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $78 |
| AstraZeneca(2 entities) | 3 | $48 |
| Seagen Inc. | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| GSK | 2 | $38 |
| EMD Serono, Inc. | 2 | $31 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Bristol Myers Squibb | 1 | $19 |
| Bayer | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Acceleron Pharma, Inc. | 1 | $12 |
How this compares
$3,065 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $11,187 |
| Letrozole | 34 | $952 |
| Anastrozole | 22 | $553 |
| Hydroxyurea | 17 | $322 |
| Prochlorperazine Maleate | 14 | $256 |
| Ondansetron OdtOndansetron | 14 | $245 |
| Ondansetron Hcl | 11 | $212 |
| Oxycodone Hcl | 14 | $195 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $192 |
| Dexamethasone | 12 | $154 |
| Gabapentin | 12 | $114 |
| Prednisone | 15 | $46 |
| Levothyroxine Sodium | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Monroe
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.